Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.
Recruiting
Observational Study
Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 60 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 385 (estimated)
- Sponsor
- Gia Dinh People Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions.
Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* aged 60 years and older
* high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
* receives reperfusion intervention.
Exclusion Criteria:
* Acute coronary syndrome due to stent thrombosis, or cor…
Contacts